According to EAN/PNS 2021 recommendations for CIDP, anti-MAG-ab should also be tested in all patients fulfilling CIDP diagnostic criteria and in presence of IgM monoclonal gammopathy (90, 94). The gene discussed is MAG; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.